Literature DB >> 24338572

Which patients with eosinophilic esophagitis (EoE) should receive elemental diets versus other therapies?

Kathryn A Peterson1, Kathleen K Boynton.   

Abstract

Eosinophilic esophagitis (EoE) has increasingly been identified in both children and adults. The aim of therapies is to alleviate symptoms while reducing the esophageal inflammation. Mechanical dilation is effective at relieving symptoms, but without the benefit of controlling disease inflammation. Topical steroids appear to be effective at controlling both symptoms and esophageal eosinophilia. Recurrence rates are high once steroids are discontinued. For dietary modification, both the elimination of select, specific foods and the complete elimination of food proteins via amino acid formulas have been looked at. Both forms of dietary modification are effective. Elemental diet, although not an ideal first-line therapy for EoE, provides insight into the etiology of unusual or refractory EoE. The contribution of unusual food antigens to EoE may be determined via the use of amino-acid-based formulas in patients with EoE.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24338572     DOI: 10.1007/s11894-013-0364-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  43 in total

1.  Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.

Authors:  Ranjan Dohil; Robert Newbury; Lyman Fox; John Bastian; Seema Aceves
Journal:  Gastroenterology       Date:  2010-05-07       Impact factor: 22.682

2.  Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.

Authors:  Evan S Dellon; Xiaoxin Chen; C Ryan Miller; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

3.  Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet.

Authors:  Jonathan M Spergel; Terri F Brown-Whitehorn; Antonella Cianferoni; Michele Shuker; Mei-Lun Wang; Ritu Verma; Chris A Liacouras
Journal:  J Allergy Clin Immunol       Date:  2012-06-27       Impact factor: 10.793

4.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.

Authors:  Alain M Schoepfer; Ekaterina Safroneeva; Christian Bussmann; Tanja Kuchen; Susanne Portmann; Hans-Uwe Simon; Alex Straumann
Journal:  Gastroenterology       Date:  2013-08-13       Impact factor: 22.682

5.  Ringed oesophagus and idiopathic eosinophilic oesophagitis in adults: an association in two cases.

Authors:  P Cantù; P Velio; A Prada; R Penagini
Journal:  Dig Liver Dis       Date:  2005-02       Impact factor: 4.088

6.  Eosinophilic esophagitis: clinical features, endoscopic findings and response to treatment.

Authors:  Robert Enns; Pooya Kazemi; Wiley Chung; Mitchell Lee
Journal:  Can J Gastroenterol       Date:  2010-09       Impact factor: 3.522

Review 7.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

8.  Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults.

Authors:  Amindra S Arora; Jean Perrault; Thomas C Smyrk
Journal:  Mayo Clin Proc       Date:  2003-07       Impact factor: 7.616

9.  Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula.

Authors:  K J Kelly; A J Lazenby; P C Rowe; J H Yardley; J A Perman; H A Sampson
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

10.  Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids.

Authors:  A M Schoepfer; J Gschossmann; U Scheurer; F Seibold; A Straumann
Journal:  Endoscopy       Date:  2008-02       Impact factor: 10.093

View more
  4 in total

Review 1.  Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches.

Authors:  Bharati Kochar; Evan S Dellon
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-12       Impact factor: 3.869

2.  British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.

Authors:  Anjan Dhar; Hasan N Haboubi; Stephen E Attwood; Marcus K H Auth; Jason M Dunn; Rami Sweis; Danielle Morris; Jenny Epstein; Marco R Novelli; Hannah Hunter; Amanda Cordell; Sharon Hall; Jamal O Hayat; Kapil Kapur; Andrew Robert Moore; Carol Read; Sarmed S Sami; Paul J Turner; Nigel J Trudgill
Journal:  Gut       Date:  2022-05-23       Impact factor: 31.793

Review 3.  Eosinophilic esophagitis: From pathophysiology to treatment.

Authors:  Alessandra D'Alessandro; Dario Esposito; Marcella Pesce; Rosario Cuomo; Giovanni Domenico De Palma; Giovanni Sarnelli
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 4.  Evidence-based treatments for eosinophilic esophagitis: insights for the clinician.

Authors:  Sara Feo-Ortega; Alfredo J Lucendo
Journal:  Therap Adv Gastroenterol       Date:  2022-01-19       Impact factor: 4.409

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.